文献速递眼底病与葡萄膜炎青光眼角膜与眼表疾病

线粒体自噬:眼病病理中的新兴靶点

Mitophagy: An Emerging Target in Ocular Pathology.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

本文综述线粒体稳态(含分裂与融合的动态平衡)及线粒体自噬机制,并汇总Fuchs角膜内皮营养不良、原发性开角型青光眼、糖尿病视网膜病变、年龄相关性黄斑变性及多种原发性线粒体病伴眼部表型中线粒体自噬受损的研究证据,认为线粒体自噬是氧化应激和线粒体功能障碍相关眼病的可靶向机制。

要点

  • 线粒体自噬受损见于Fuchs角膜内皮营养不良、原发性开角型青光眼、糖尿病视网膜病变和年龄相关性黄斑变性。
  • 多种原发性线粒体病伴眼部表型(如MELAS、Leber遗传性视神经病变、慢性进行性眼外肌麻痹)也显示线粒体自噬受损。
  • 线粒体自噬应作为以氧化应激和线粒体功能障碍为特征的眼病治疗开发的靶向机制加以研究。

核心结论

  • 线粒体自噬受损是多种眼病病理的重要特征,应作为可靶向机制研究眼病治疗。

研究设计与样本

  • 本文为综述,汇总细胞培养、动物模型和人组织模型等研究,未报告系统检索范围。

主要发现

  • 线粒体通过ATP生成、代谢调节、氧化还原平衡、免疫信号和凋亡参与细胞功能,其动态平衡包括分裂与融合。
  • 线粒体自噬是线粒体(大)自噬的专称,参与线粒体再生与清除的循环过程。
  • Fuchs角膜内皮营养不良、原发性开角型青光眼、糖尿病视网膜病变和年龄相关性黄斑变性存在线粒体自噬受损。
  • MELAS、Leber遗传性视神经病变和慢性进行性眼外肌麻痹等原发性线粒体病伴眼部表型显示线粒体自噬受损。

临床怎么用

  • 关注以氧化应激和线粒体功能障碍为特征的眼病中线粒体自噬受损,并将其作为潜在治疗靶点。

局限性

  • 本文为综述,未报告系统检索策略、纳入排除标准或定量合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mitochondrial function is essential for the viability of aerobic eukaryotic cells, as mitochondria provide energy through the generation of adenosine triphosphate (ATP), regulate cellular metabolism, provide redox balancing, participate in immune signaling, and can initiate apoptosis. Mitochondria are dynamic organelles that participate in a cyclical and ongoing process of regeneration and autophagy (clearance), termed mitophagy specifically for mitochondrial (macro)autophagy. An imbalance in mitochondrial function toward mitochondrial dysfunction can be catastrophic for cells and has been characterized in several common ophthalmic diseases. In this article, we review mitochondrial homeostasis in detail, focusing on the balance of mitochondrial dynamics including the processes of fission and fusion, and provide a description of the mechanisms involved in mitophagy. Furthermore, this article reviews investigations of ocular diseases with impaired mitophagy, including Fuchs endothelial corneal dystrophy, primary open-angle glaucoma, diabetic retinopathy, and age-related macular degeneration, as well as several primary mitochondrial diseases with ocular phenotypes that display impaired mitophagy, including mitochondrial encephalopathy lactic acidosis stroke, Leber hereditary optic neuropathy, and chronic progressive external ophthalmoplegia. The results of various studies using cell culture, animal, and human tissue models are presented and reflect a growing awareness of mitophagy impairment as an important feature of ophthalmic disease pathology. As this review indicates, it is imperative that mitophagy be investigated as a targetable mechanism in developing therapies for ocular diseases characterized by oxidative stress and mitochondrial dysfunction.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Skeie JM, Nishimura DY, Wang CL, et al. Mitophagy: An Emerging Target in Ocular Pathology. Invest Ophthalmol Vis Sci. 2021. PMID: 33724294. doi:10.1167/iovs.62.3.22

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。